Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study
People using five or more medications are said to be receiving ‘polypharmacy’. There may be some risks associated with polypharmacy. In particular, people receiving this number of drugs may at increased risk of receiving combinations of drugs which may interact causing health problems. We reviewed the treatments received by people with HIV in the POPPY study, to evaluate whether there were risks of drug-drug interactions.